Eldridge Investment Advisors, Inc. - SPDR SERIES TRUST ownership

SPDR SERIES TRUST's ticker is SDY and the CUSIP is 78464A763. A total of 643 filers reported holding SPDR SERIES TRUST in Q2 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
Eldridge Investment Advisors, Inc. ownership history of SPDR SERIES TRUST
ValueSharesWeighting
Q3 2023$288
-5.9%
2,5000.0%0.10%
-4.0%
Q2 2023$306
-1.0%
2,5000.0%0.10%
-6.5%
Q1 2023$309
-1.3%
2,5000.0%0.11%
-1.8%
Q4 2022$313
-99.9%
2,5000.0%0.11%
+0.9%
Q3 2022$279,000
-6.1%
2,5000.0%0.11%
-3.6%
Q2 2022$297,000
-6.3%
2,500
+1.0%
0.11%
+4.7%
Q1 2022$317,000
-0.9%
2,4750.0%0.11%
+0.9%
Q4 2021$320,000
+10.0%
2,4750.0%0.11%
+1.9%
Q3 2021$291,000
-4.0%
2,4750.0%0.10%
-5.5%
Q2 2021$303,000
+4.8%
2,475
+1.0%
0.11%
-0.9%
Q1 2021$289,000
+11.2%
2,4500.0%0.11%
+1.8%
Q4 2020$260,000
+15.0%
2,4500.0%0.11%
+2.8%
Q3 2020$226,000
+1.3%
2,4500.0%0.11%
-4.5%
Q2 2020$223,000
-15.5%
2,4500.0%0.11%
-14.0%
Q4 2019$264,000
+5.2%
2,4500.0%0.13%
-0.8%
Q3 2019$251,000
+1.6%
2,4500.0%0.13%
-1.5%
Q2 2019$247,000
+1.2%
2,4500.0%0.13%
+0.8%
Q1 2019$244,000
+11.4%
2,4500.0%0.13%
-3.0%
Q4 2018$219,000
-8.4%
2,4500.0%0.14%
-11.8%
Q3 2018$239,000
+5.3%
2,4500.0%0.15%
-5.0%
Q2 2018$227,000
+1.8%
2,4500.0%0.16%
-3.6%
Q1 2018$223,000
-3.5%
2,4500.0%0.17%
-6.2%
Q4 2017$231,0002,4500.18%
Other shareholders
SPDR SERIES TRUST shareholders Q2 2018
NameSharesValueWeighting ↓
Joel Isaacson & Co., LLC 1,858,029$187,438,00027.28%
Stratford Consulting, LLC 347,992$35,105,00012.40%
O'Dell Group, LLC 198,843$20,059,00012.16%
Wolff Financial Management LLC 145,042$14,632,00011.26%
MARINO, STRAM & ASSOCIATES LLC 148,967$15,028,00011.01%
Jackson, Grant Investment Advisers, Inc. 182,221$18,382,00010.71%
Spectrum Asset Management, Inc. (NB/CA) 153,317$15,467,0009.71%
Osbon Capital Management LLC 75,156$7,582,0008.06%
EisnerAmper Wealth Management Corporate Benefits, LLC 101,866$10,276,0007.64%
CRA Financial Services, LLC 122,399$12,348,0007.42%
View complete list of SPDR SERIES TRUST shareholders